Articles with public access mandates - John HartLearn more
Not available anywhere: 4
Epidermal Growth Factor Receptor Is Required for Colonic Tumor Promotion by Dietary Fat in the Azoxymethane/Dextran Sulfate Sodium Model: Roles of Transforming Growth Factor …
U Dougherty, D Cerasi, I Taylor, M Kocherginsky, U Tekin, S Badal, L Aluri, ...
Clinical Cancer Research 15 (22), 6780-6789, 2009
Mandates: US National Institutes of Health
Upregulation of glycogen synthase kinase 3β in human colorectal adenocarcinomas correlates with accumulation of CTNNB1
HL Wang, J Hart, L Fan, R Mustafi, M Bissonnette
Clinical colorectal cancer 10 (1), 30-36, 2011
Mandates: US National Institutes of Health
Design evolution of the Giant Magellan telescope integral field spectrograph, GMTIFS
R Sharp, D Adams, G Bloxham, R Boz, D Bundy, D Chandler, ...
Ground-based and Airborne Instrumentation for Astronomy VII 10702, 597-608, 2018
Mandates: Australian Research Council
Reduced MFAP5 expression in stroma of gallbladder adenocarcinoma and its potential diagnostic utility
L Zhao, L Xu, A Hemmerich, NL Ferguson, CD Guy, SJ McCall, ...
Virchows Archiv 478, 427-434, 2021
Mandates: US National Institutes of Health
Available somewhere: 65
2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection
AJ Demetris, C Bellamy, SG Hübscher, J O’leary, PS Randhawa, S Feng, ...
American Journal of Transplantation 16 (10), 2816-2835, 2016
Mandates: UK Medical Research Council
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process
C Bennett, N Vakil, J Bergman, R Harrison, R Odze, M Vieth, S Sanders, ...
Gastroenterology 143 (2), 336-346, 2012
Mandates: US National Institutes of Health, Cancer Research UK
Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case–control study
DT Rubin, D Huo, JA Kinnucan, MS Sedrak, NE McCullom, AP Bunnag, ...
Clinical gastroenterology and hepatology 11 (12), 1601-1608. e4, 2013
Mandates: US National Institutes of Health
Genomic heterogeneity as a barrier to precision medicine in gastroesophageal adenocarcinoma
E Pectasides, MD Stachler, S Derks, Y Liu, S Maron, M Islam, L Alpert, ...
Cancer discovery 8 (1), 37-48, 2018
Mandates: US National Institutes of Health
Liver autoimmunity triggered by microbial activation of natural killer T cells
J Mattner, PB Savage, P Leung, SS Oertelt, V Wang, O Trivedi, ...
Cell host & microbe 3 (5), 304-315, 2008
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms
BC Yan, C Gong, J Song, T Krausz, M Tretiakova, E Hyjek, H Al-Ahmadie, ...
The American journal of surgical pathology 34 (8), 1147-1154, 2010
Mandates: US National Institutes of Health
BNip3 regulates mitochondrial function and lipid metabolism in the liver
D Glick, W Zhang, M Beaton, G Marsboom, M Gruber, MC Simon, J Hart, ...
Molecular and cellular biology 32 (13), 2570-2584, 2012
Mandates: US National Institutes of Health
Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes
B Christensen, SB Hanauer, J Erlich, O Kassim, PR Gibson, JR Turner, ...
Clinical Gastroenterology and Hepatology 15 (10), 1557-1564. e1, 2017
Mandates: US National Institutes of Health
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes
JR Pekow, U Dougherty, R Mustafi, H Zhu, M Kocherginsky, DT Rubin, ...
Inflammatory bowel diseases 18 (1), 94-100, 2012
Mandates: US National Institutes of Health
EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators
H Zhu, U Dougherty, V Robinson, R Mustafi, J Pekow, S Kupfer, YC Li, ...
Molecular cancer research 9 (7), 960-975, 2011
Mandates: US National Institutes of Health
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma
SB Maron, L Alpert, HA Kwak, S Lomnicki, L Chase, D Xu, E O'Day, ...
Cancer discovery 8 (6), 696-713, 2018
Mandates: US National Institutes of Health
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis
JR Pekow, JT Hetzel, JA Rothe, SB Hanauer, JR Turner, J Hart, ...
Inflammatory bowel diseases 16 (8), 1352-1356, 2010
Mandates: US National Institutes of Health
Estrogen receptor‐β protects against colitis‐associated neoplasia in mice
D Saleiro, G Murillo, RV Benya, M Bissonnette, J Hart, RG Mehta
International journal of cancer 131 (11), 2553-2561, 2012
Mandates: US National Institutes of Health
Histologic healing is more strongly associated with clinical outcomes in ileal Crohn’s disease than endoscopic healing
B Christensen, J Erlich, PR Gibson, JR Turner, J Hart, DT Rubin
Clinical Gastroenterology and Hepatology 18 (11), 2518-2525. e1, 2020
Mandates: US National Institutes of Health
miR-193a-3p is a key tumor suppressor in ulcerative colitis–associated colon cancer and promotes carcinogenesis through upregulation of IL17RD
J Pekow, K Meckel, U Dougherty, Y Huang, X Chen, A Almoghrabi, ...
Clinical Cancer Research 23 (17), 5281-5291, 2017
Mandates: US National Institutes of Health
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia
VJA Konda, MGH Ruiz, A Koons, J Hart, SY Xiao, UD Siddiqui, ...
Clinical Gastroenterology and Hepatology 12 (12), 2002-2010. e2, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program